Skip to main content
OpenTrials

Clinical trial condition

Infections, Streptococcal

Explore clinical trials studying Infections, Streptococcal. Study availability and eligibility vary by location and protocol.

58 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Streptococcal trial results

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

NCT01485406

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Berchtesgaden, Bavaria, Germany
  • GSK Investigational Site Braunatal, Hesse, Germany
  • GSK Investigational Site Berlin, Germany
View Trial Details
Completed

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

NCT00624819

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Dębica, Poland
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Oleśnica, Poland
View Trial Details
Completed

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

NCT00839254

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Ear Diseases, +11 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 15 locations
View Trial Details
Completed

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

NCT00907777

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Nördlingen, Bavaria, Germany
  • GSK Investigational Site Bad Oeynhausen, North Rhine-Westphalia, Germany
  • GSK Investigational Site Goch, North Rhine-Westphalia, Germany
View all 17 locations
View Trial Details
Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

NCT00985751

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Chomutov, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Náchod, Czechia
  • GSK Investigational Site Odolena Voda, Czechia
View Trial Details
Completed

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

NCT00609492

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Ioannina, Greece
  • GSK Investigational Site Thessaloniki, Greece
View Trial Details

Related conditions